Barclays Downgrades IMS Health Holdings (IMS) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
IMS Health Announces $250 Million Share Repurchase Authorization
December 17, 2015 6:30 AM ESTDANBURY, Conn.--(BUSINESS WIRE)-- IMS Health Holdings, Inc. (NYSE: IMS) today announced that its board of directors approved a stock repurchase program authorizing the repurchase of up to $250 million of its common stock.
The share repurchase program does not obligate the company to repurchase any particular amount of common stock, and it could be modified, suspended or discontinued at any time. The timing and amount of repurchases are determined by IMS Healths management at its discretion based on a variety of factors such as... More
